(1)
In Silico Study of Secondary Metabolite Compound from Noni Fruit (Morinda Citrifolia) As Potential Drug Candidates for Type 2 Diabetes Mellitus Targeting PPAR-γ. ijcs 2025, 14 (1), 38-46. https://doi.org/10.15294/ijcs.v14i1.8966.